Form 4: Cross Country Healthcare Director Janice Nevin Reports Stock Transactions

Sentiment:

SEC Form 4


Director Janice Nevin of Cross Country Healthcare reports acquisition and disposal of common stock related to vesting of restricted shares and tax obligations.

Summary

  • On June 1, 2024, Janice Elizabeth Nevin, a director of Cross Country Healthcare, acquired 9,921 shares of common stock.
  • These shares were acquired as restricted stock that will vest on June 1, 2025.
  • Also on June 1, 2024, Nevin disposed of 2,150 shares of common stock at a price of $15.12 per share.
  • These shares were withheld to satisfy tax withholding obligations for restricted stock that vested on the same date.
  • Following these transactions, Nevin beneficially owns 33,606 shares of Cross Country Healthcare stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral as the filing reflects routine stock transactions related to compensation and tax obligations. There is no indication of significant positive or negative implications for the company.

Positives

  • The acquisition of restricted stock indicates continued alignment of the director's interests with the company's long-term performance.

Negatives

  • The disposal of shares to cover tax obligations, while routine, slightly reduces the director's overall holdings.

Industry Context

This filing is a routine disclosure of stock transactions by a company insider, which is common in publicly traded companies. It provides transparency to investors regarding the ownership positions of key individuals.

Comparison to Industry Standards

  • Similar filings are common among directors and officers of publicly traded companies like Cross Country Healthcare, such as AMN Healthcare and HCA Healthcare.
  • These filings are mandated by the SEC to ensure transparency and prevent insider trading, aligning with standard corporate governance practices.

Stakeholder Impact

  • The transactions have a minimal direct impact on stakeholders, as they are related to internal compensation and tax matters.

Key Dates

DateDescription
06/01/2024Date of stock acquisition and disposal.
06/01/2025Vesting date for the acquired restricted shares.
06/04/2024Date of signature for the SEC filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.